Navigation Links
SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO
Date:11/16/2010

AIX-EN-PROVENCE, France, Nov. 16, 2010 /PRNewswire/ -- SuperSonic Imagine, the innovative ultrasound medical imaging company, is pleased to announce Gordon Waldron has been named as Executive Vice President and CFO. As a member of the board of directors, he will be responsible for driving all of SuperSonic Imagine's key strategic and commercial partnerships as well as overseeing the company's financial development plan.

Prior to joining SuperSonic Imagine in September 2010, Mr. Waldron spent five years as CFO for the French biotech company Novexel where he raised 50 million euros in 2006, negotiated a preclinical license agreement which brought the company a 75 million euros upfront payment in 2008 and directed a trade sale process resulting in the acquisition of Novexel by AstraZeneca for cash consideration of approximately $500 million in 2009.

Before Novexel, he spent eight years as VP Finance with Synt:em (Nimes, France) where he raised 32 million euros in three financing rounds.

He also spent five years with Texas Instruments, first as Finance Director for a French subsidiary, then as Group Finance Manager (based in the UK) covering 17 entities and a distributor network for Texas Instruments Software in Europe, the Middle East and Africa.

Mr. Waldron started his career with Spie Batignolles at the Head Office near Paris before becoming a controller of the company's US subsidiaries based in Pittsburgh.

He graduated from Duke University (USA) in 1988 and has both American and British nationalities.

Mr. Waldron commented, "I am pleased to join such a high caliber group of people working in such an innovative environment. This mix has already produced some impressive R&D achievements as the company quickly differentiated itself through the creation of a software based ultrasound technology. The Aixplorer® MultiWave™ Ultrasound system not only offers exceptional image quality but also has the unique ability to provide tissue elasticity assessment which is fully reproducible and independent of the user's experience, skill and scanning technique. The next chapter will be to leverage this R&D excellence through commercial alliances and to extend applications for the Aixplorer platform from breast alone to multiple other organs."

SuperSonic Imagine Founder and CEO, Dr. Jacques Souquet (PhD.) remarked, "We have built a very strong management team at SuperSonic Imagine and having someone of Gordon's experience and stature enhances our capabilities. In today's global business environment and particularly in medical imaging, having the ability to drive strategic partnerships is critical. Gordon brings this and other know-how to the company and will be a great asset."

About SuperSonic Imagine:

Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine is an innovative, multinational medical imaging company dedicated to developing a revolutionary ultrasound system: the Aixplorer®. The system leverages a unique MultiWave™ technology that enables the user to detect, characterize and, in the future, treat palpable and non-palpable masses. Engineers from all over the world have joined the SuperSonic Imagine team and the company now has offices in Aix-en-Provence, Seattle, London and Munich. SuperSonic Imagine holds the exclusive rights to 25 international patients and submissions in diagnostic imaging and therapy applications that are solely owned and solely used by the company.

For further information about SuperSonic Imagine please visit our website: http://www.supersonicimagine.fr.   www.supersonicimagine.com


'/>"/>
SOURCE SuperSonic Imagine
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016  According to Kalorama Information, ... billion in 2015.  Though these are challenging times ... opportunity for success for companies that remain optimistic ... of new growth prospects medical device companies spend ... and development (R&D) than do companies in other ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on ... presentation entitled "High doses of biotin in progressive multiple sclerosis: ... by Professor Ayman Tourbah , Principal Investigator of the ... Academy of Neurology (EAN) in Copenhagen, Denmark ... take place on Sunday, 29 May 2016 from 14:45 to ...
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... In response to meager public ... unaware of the plight of aphasia. In collaboration with the American Aphasia Association, ... , The link between stroke and aphasia is relatively unknown, but through collaboration ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in the health ... of leaders in the nursing and health care industry. It also provides insight to ... Christian University. , As the nursing industry is coming out of one of ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its ... partner for the Tamika Catchings Legacy Tour that will commemorate the Indiana ... hardwood basketball surfaces in all forms and levels of the game, Connor Sports has ...
Breaking Medicine News(10 mins):